American Healthcare REIT, Inc. (NYSE:AHR – Get Free Report) EVP Mark Foster sold 2,000 shares of the stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $55.39, for a total transaction of $110,780.00. Following the sale, the executive vice president directly owned 51,617 shares of the company’s stock, valued at approximately $2,859,065.63. This trade represents a 3.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
American Healthcare REIT Price Performance
NYSE:AHR opened at $56.45 on Wednesday. The business’s 50-day moving average is $55.05 and its 200 day moving average is $51.61. American Healthcare REIT, Inc. has a 12 month low of $40.00 and a 12 month high of $58.70. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 0.24. The company has a market capitalization of $12.31 billion, a P/E ratio of 83.01, a P/E/G ratio of 1.56 and a beta of 0.76.
American Healthcare REIT (NYSE:AHR – Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.14 by $0.02. American Healthcare REIT had a return on equity of 3.63% and a net margin of 4.84%.The company had revenue of $674.25 million during the quarter, compared to analyst estimates of $645.30 million. During the same quarter last year, the business posted $0.42 earnings per share. The firm’s revenue was up 24.3% on a year-over-year basis. American Healthcare REIT has set its FY 2026 guidance at 2.150-2.190 EPS. On average, equities research analysts forecast that American Healthcare REIT, Inc. will post 2.18 earnings per share for the current fiscal year.
American Healthcare REIT Dividend Announcement
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of the business. Thames Capital Management LLC purchased a new stake in shares of American Healthcare REIT during the 4th quarter valued at approximately $4,042,000. Strs Ohio increased its stake in American Healthcare REIT by 48.2% during the first quarter. Strs Ohio now owns 348,100 shares of the company’s stock worth $16,416,000 after purchasing an additional 113,200 shares during the period. Hsbc Holdings PLC lifted its holdings in American Healthcare REIT by 61.9% during the 4th quarter. Hsbc Holdings PLC now owns 345,590 shares of the company’s stock worth $16,259,000 after buying an additional 132,172 shares in the last quarter. Cbre Investment Management Listed Real Assets LLC grew its stake in American Healthcare REIT by 14.5% during the 4th quarter. Cbre Investment Management Listed Real Assets LLC now owns 1,504,685 shares of the company’s stock worth $70,810,000 after purchasing an additional 190,546 shares in the last quarter. Finally, Eurizon Capital SGR S.p.A. purchased a new stake in shares of American Healthcare REIT during the fourth quarter worth approximately $4,013,000. 16.68% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several research firms recently commented on AHR. Royal Bank Of Canada boosted their price objective on shares of American Healthcare REIT from $56.00 to $61.00 and gave the stock an “outperform” rating in a research note on Friday, August 14th. Barclays upped their target price on American Healthcare REIT from $61.00 to $66.00 and gave the company an “overweight” rating in a research report on Monday. Citigroup reissued a “buy” rating and set a $65.00 price target (up from $55.00) on shares of American Healthcare REIT in a research report on Monday, August 10th. Compass Point started coverage on shares of American Healthcare REIT in a report on Tuesday, July 21st. They issued a “buy” rating and a $70.00 price objective on the stock. Finally, Truist Financial increased their price objective on shares of American Healthcare REIT from $57.00 to $61.00 and gave the stock a “buy” rating in a research note on Friday, August 14th. Twelve research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, American Healthcare REIT presently has a consensus rating of “Moderate Buy” and a consensus target price of $61.67.
View Our Latest Stock Analysis on AHR
About American Healthcare REIT
American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.
Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.
Featured Articles
- Five stocks we like better than American Healthcare REIT
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
